Cyber Sense Medical Billing logo

Dermatology Biopsy Documentation: Technique and Site

Improve dermatology biopsy documentation with technique, site, specimen tracking, and coding checks that support accurate claims and clearer clinical records.

By Cyber Sense Billing Team · Published · Updated

Start with the procedure actually performed

A dermatology biopsy claim should communicate what tissue was sampled, how it was obtained, and which lesion produced the specimen. The word biopsy alone does not establish the appropriate procedure family. Tangential, punch, and incisional techniques have different reporting structures, and a specimen sent to pathology does not automatically make the original procedure a biopsy. Therapeutic shaving and complete excision require their own analysis. Establish the clinician's intent and operative actions before selecting a code. The record should explain the reason for sampling and describe the technique sufficiently for another clinician or coder to understand the service without relying on a charge-entry shortcut.

Make every sampled lesion identifiable

Use a consistent lesion identifier across the examination, procedure note, specimen label, requisition, and pathology result. An entry such as left upper back, lateral to the scapular border is more useful than back lesion when several abnormalities are present. Document laterality when applicable, distinguish nearby lesions, and record the clinical concern associated with each sample. A diagram or clinical photograph can support identification when appropriately maintained, but it should not replace a written site description. Lesion size may support clinical context even when it does not determine the biopsy code. Avoid copying a previous visit's site into today's note without confirming that the same lesion was sampled.

Separate technique selection from specimen appearance

Describe the instrument and tissue acquisition rather than asking the biller to infer technique from the pathology container. A circular specimen does not independently establish how the procedure was performed. Likewise, sutures do not automatically convert a punch biopsy into an excision. When multiple biopsy techniques are used, consult the current CPT instructions for selecting the primary service and applicable additional-lesion codes; do not simply submit a standalone primary code for every specimen. CMS's integumentary NCCI chapter also explains that biopsy procurement from a lesion removed during the same encounter is generally included in that removal. A genuinely separate sampled lesion requires distinct documentation. 1

Hypothetical scenario: three lesions, two techniques

A dermatologist samples a changing pigmented lesion on the right shoulder using a tangential technique, obtains a punch sample from an inflammatory plaque on the left thigh, and completely removes a separate symptomatic lesion on the neck. Staff initially enter three biopsy charges because three containers leave the office. During review, the coder identifies that the neck procedure was therapeutic removal rather than diagnostic sampling. The clinician clarifies the operative description through a dated addendum based on the original encounter. The revised claim follows the appropriate procedure families and multiple-biopsy instructions. Each container retains its own site identifier, allowing the later pathology reports to reconcile with the clinical record without changing which procedures actually occurred.

Checklist before releasing the claim

A useful biopsy checklist follows the encounter from clinical intent through specimen reconciliation. It should identify missing facts rather than force staff to choose a code despite uncertainty. Establish who answers queries and how unresolved cases remain visible before filing deadlines. Do not ask a clinician to select a higher-paying technique or add a diagnosis merely to clear an edit. Review mixed-technique encounters and biopsies performed alongside removal procedures with particular care.

  • Confirm the indication, exact site, laterality, lesion identifier, and documented sampling technique.
  • Reconcile the number of sampled lesions with specimen labels and the pathology requisition.
  • Apply current primary and additional-lesion instructions rather than counting containers as standalone procedures.
  • Check whether another procedure on the same lesion already includes biopsy procurement.
  • Resolve discrepancies through a traceable query before submitting the affected claim line.

Coding cautions and payer variations

A separate lesion can support distinct-service analysis, but it does not automatically justify any modifier. Review the actual procedure pair, applicable edit, modifier indicator, and payer instructions. Medicare NCCI policy is not a substitute for a commercial plan's published processing rules, and Medicaid has its own NCCI framework. A diagnosis should reflect the documented condition or reason for the service; uncertainty about behavior must not be confused with a pathology-defined neoplasm of uncertain behavior. Practices should maintain date-specific references because edits and instructions change. CMS describes its policy manual as an annually updated explanation of NCCI edit rationale, not a complete payer coverage guarantee. 2

Close the loop on queries and results

Biopsy documentation quality is also a patient-safety issue. Assign responsibility for tracking outstanding pathology, matching returned results to the correct lesion, and escalating missing or inconsistent reports. Billing staff should not silently relabel a specimen or overwrite a site to make records agree. Preserve the original documentation and the correction trail. Periodic reviews can distinguish recurring technique omissions from occasional labeling errors and guide focused staff education. For help aligning clinical documentation, coding review, and charge release, request a Cyber Sense consultation. A useful discussion starts with representative de-identified encounters and the practice's actual workflow, not an assumption that every biopsy problem requires more claim modifiers.

Frequently asked questions

Does sending tissue to pathology make the procedure a biopsy?

No. Code selection depends on the documented procedure and its purpose, not merely on pathology submission. Therapeutic removal can produce a specimen without becoming a separately reportable biopsy.

Can a biopsy and removal both be billed on the same date?

Sometimes, particularly for different lesions. Same-lesion biopsy procurement is generally included in removal. Review the documented circumstances, current edits, and any narrowly applicable exceptions before reporting both.

Sources and further reading

Need help with dermatology billing? See our Dermatology medical billing services.

Related articles

This article is general information, not legal or coding advice. Always check current CPT®, ICD-10-CM, CMS and payer guidance. Questions? Contact us.

Let's talk about your practice

Ready for cleaner claims and steadier cash flow?

Speak with our billing experts — free consultation, no obligation. Complete Billing from 4% of collections.

Schedule a consultation